CIK 0001818331
- Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851966622
- Phone
- +1 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-22 | Saad Kareem CHIEF TRANSFORMATION OFFICER | Sale | −193 | $3.24 | $625 | 24,467 |
| 2024-01-19 | Saad Kareem CHIEF TRANSFORMATION OFFICER | Option exercise | +546 | 24,660 | ||
| 2024-01-19 | Saad Kareem CHIEF TRANSFORMATION OFFICER | Option exercise · Restricted Stock Unit | −546 | 2,183 | ||
| 2024-01-11 | Ryan Jason Director | Gift | −73,614 | 0 | ||
| 2024-01-03 | Saad Kareem Chief Transformation Officer | Sale | −105 | $2.58 | $271 | 24,114 |
| 2024-01-01 | Saad Kareem Chief Transformation Officer | Option exercise | +273 | 24,219 | ||
| 2024-01-01 | Saad Kareem Chief Transformation Officer | Option exercise · Restricted Stock Unit | −273 | 2,455 | ||
| 2023-12-31 | Ryan Jason Executive Chairman | Option exercise | +67,780 | 73,614 | ||
| 2023-12-31 | Ryan Jason Executive Chairman | Option exercise · Restricted Stock Unit | −21,780 | 0 | ||
| 2023-12-31 | Ryan Jason Executive Chairman | Option exercise · Restricted Stock Unit | −46,000 | 0 | ||
| 2023-12-18 | Stueland Katherine Chief Executive Officer | Sale | −11,734 | $2.16 | $25K | 52,578 |
| 2023-12-18 | Saad Kareem Chief Transformation Officer | Sale | −1,700 | $2.16 | $4K | 23,946 |
| 2023-12-18 | Feeley Kevin Chief Financial Officer | Sale | −2,948 | $2.16 | $6K | 23,035 |
| 2023-12-16 | Stueland Katherine Chief Executive Officer | Option exercise | +18,750 | 64,312 | ||
| 2023-12-16 | Stueland Katherine Chief Executive Officer | Option exercise · Restricted Stock Unit | −18,750 | 243,750 | ||
| 2023-12-16 | Saad Kareem Chief Transformation Officer | Option exercise | +5,114 | 25,646 | ||
| 2023-12-16 | Saad Kareem Chief Transformation Officer | Option exercise · Restricted Stock Unit | −5,114 | 66,476 | ||
| 2023-12-16 | Feeley Kevin Chief Financial Officer | Option exercise | +7,197 | 25,983 | ||
| 2023-12-16 | Feeley Kevin Chief Financial Officer | Option exercise · Restricted Stock Unit | −7,197 | 93,560 | ||
| 2023-12-11 | Stueland Katherine Chief Executive Officer | Sale | −3,673 | $1.61 | $6K | 45,562 |
Page 32 of 36 · 718 trades